The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity-Reference-Cited by-同舟云学术

The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity

Published:2016-11-03 Issue:11 Volume:11 Page:e0165139
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Mas-y-Mas Sarah,Barbon Marta,Teyssier Catherine,Déméné Hélène,Carvalho João E.,Bird Louise E.,Lebedev Andrey,Fattori Juliana,Schubert Michael,Dumas Christian,Bourguet William,le Maire Albane

Funder

Association pour la Recherche sur le Cancer

Fundação para a Ciência e a Tecnologia

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference56 articles.

1. MLL5, a homolog of Drosophila trithorax located within a segment of chromosome band 7q22 implicated in myeloid leukemia;BM Emerling;Oncogene,2002

2. Impaired function of primitive hematopoietic cells in mice lacking the Mixed-Lineage-Leukemia homolog MLL5;V Madan;Blood,2009

3. Loss of MII5 results in pleiotropic hematopoietic defects, reduced neutrophil immune function, and extreme sensitivity to DNA demethylation;M Heuser;Blood,2009

4. MII5 contributes to hematopoietic stem cell fitness and homeostasis;Y Zhang;Blood,2009

5. Mll5 is required for normal spermatogenesis;DB Yap;PLoS One,2011

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining Biological and Biochemical Functions of Noncanonical SET Domain Proteins;Journal of Molecular Biology;2023-10

2. The protein methylation network in yeast: A landmark in completeness for a eukaryotic post-translational modification;Proceedings of the National Academy of Sciences;2023-05-30

3. An Alternative Splicing Variant of the Mixed-Lineage Leukemia 5 Protein Is a Cellular Adhesion Receptor for ScaA of Orientia tsutsugamushi;mBio;2023-02-28

4. Neurobehavioral characteristics of mice with SETD5 mutations as models of IDD23 and KBG syndromes;Frontiers in Genetics;2023-01-04

5. ASXL1/2 mutations and myeloid malignancies;Journal of Hematology & Oncology;2022-09-06